Summit Therapeutics Inc (SMMT)

Summit Therapeutics Inc Azioni (SMMT) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	32.45% 0.179	0.265	-0.027	0.584	-
Operating Expenses	75.31% 36.39	20.76	15.77	537.74	21.43
Benefits Costs and Expenses	70.65% 36.75	21.53	14.69	542.96	79.49
Costs And Expenses	75.31% 36.39	20.76	15.77	537.74	26.99
Operating Income/Loss	76.70% -36.21	-20.49	-15.79	-537.15	-20.30
Nonoperating Income/Loss	53.99% -0.357	-0.776	1.077	-5.222	1.07
Income/Loss From Continuing Operations Before Tax	71.93% -36.57	-21.27	-14.72	-542.38	-79.49
Income/Loss From Continuing Operations After Tax	71.93% -36.57	-21.27	-14.72	-542.38	-19.23
Net Income/Loss	71.93% -36.57	-21.27	-14.72	-542.38	-19.23
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	96.09% 27.28	697.74	697.69	378.16	78.23
Diluted Average Shares	96.09% 27.28	697.74	697.69	378.16	78.23
Basic Earnings Per Share	66.67% -0.01	-0.03	-0.02	-1.43	0.11
Diluted Earnings Per Share	66.67% -0.01	-0.03	-0.02	-1.43	0.11
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-